Article
Unveiling chronic spontaneous urticaria pathophysiology through systems biology
29 Dec 2022
Abstract excerpt
BACKGROUND: Chronic spontaneous urticaria (CSU) is a rare, heterogeneous, severely debilitating, and often poorly controlled skin disease resulting in an itchy eruption that can be persistent. Antihistamines and omalizumab, an anti-IgE mAb, are the only licensed therapies. Although CSU pathogenesis is not yet fully understood, mast cell activation through the IgE:high-affinity IgE receptor (FcεRI) axis appears...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
